Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

[1]  G. Kaushik,et al.  Honokiol inhibits melanoma stem cells by targeting notch signaling , 2015, Molecular carcinogenesis.

[2]  B. Su,et al.  MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis , 2015, Tumor Biology.

[3]  G. Kaushik,et al.  Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. , 2014, American journal of surgery.

[4]  J. Bussink,et al.  The unfolded protein response as a target for cancer therapy. , 2014, Biochimica et biophysica acta.

[5]  P. Abbe,et al.  Preview : Published ahead of advance online publication Inhibition of Melanogenesis by the Antidiabetic Metformin , 2014 .

[6]  A. Eggermont,et al.  eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies , 2014, Nature.

[7]  M. Herlyn,et al.  Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.

[8]  S. Shenolikar.  Dangerous liaisons: flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas. , 2014, The Journal of clinical investigation.

[9]  G. Garçon,et al.  Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor , 2013, Oncotarget.

[10]  B. Lefkove,et al.  Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78 , 2013, British Journal of Cancer.

[11]  P. Abbe,et al.  Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner , 2013, Molecular Cancer Therapeutics.

[12]  C. Goding.  The path of least resistance: enhancing the effectiveness of BRAF inhibitors , 2013, Pigment cell & melanoma research.

[13]  P. Lambin,et al.  PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS , 2013, Proceedings of the National Academy of Sciences.

[14]  Afshin Samali,et al.  New directions in ER stress-induced cell death , 2013, Apoptosis.

[15]  D. Maddalo,et al.  The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment , 2013, Front. Pharmacol..

[16]  K. Flaherty,et al.  Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.

[17]  Y Usson,et al.  Generalization of the polar representation in time domain fluorescence lifetime imaging microscopy for biological applications: practical implementation , 2012, Journal of microscopy.

[18]  Zongwei Li,et al.  Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. , 2012, Biochimica et biophysica acta.

[19]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[20]  S. Shankar,et al.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.

[21]  P. Bahadoran,et al.  Metformin inhibits melanoma development through autophagy and apoptosis mechanisms , 2011, Cell Death and Disease.

[22]  A. Aplin,et al.  Mechanisms of resistance to RAF inhibitors in melanoma , 2011, The Journal of investigative dermatology.

[23]  Y. Usson,et al.  Quantitative comparison of polar approach versus fitting method in time domain FLIM image analysis , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[24]  J. Ortonne,et al.  Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth , 2011, Cell Death and Differentiation.

[25]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[26]  Marek Michalak,et al.  Quality control in the endoplasmic reticulum. , 2010, Seminars in cell & developmental biology.

[27]  Shing-Hwa Liu,et al.  Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. , 2010, Cancer letters.

[28]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[29]  K. Smalley.  Understanding melanoma signaling networks as the basis for molecular targeted therapy. , 2010, The Journal of investigative dermatology.

[30]  C. Spriet,et al.  Three‐dimensional polar representation for multispectral fluorescence lifetime imaging microscopy , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[31]  V. Sondak,et al.  Targeted therapy in melanoma. , 2013, Clinics in dermatology.

[32]  E. Morselli,et al.  Anti- and pro-tumor functions of autophagy. , 2009, Biochimica et biophysica acta.

[33]  C. Spriet,et al.  Optimized protocol of a frequency domain fluorescence lifetime imaging microscope for FRET measurements , 2009, Microscopy research and technique.

[34]  P. Bahadoran,et al.  In vitro and in vivo anti-melanoma effects of ciglitazone. , 2009, The Journal of investigative dermatology.

[35]  R. Scolyer,et al.  Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma , 2009, Histopathology.

[36]  P. Codogno,et al.  Does autophagy have a license to kill mammalian cells? , 2009, Cell Death and Differentiation.

[37]  F. Rizzi,et al.  Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[38]  G. Shore,et al.  The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family , 2008, Oncogene.

[39]  H. Mukhtar,et al.  Multitargeted therapy of cancer by green tea polyphenols. , 2008, Cancer letters.

[40]  E. Gratton,et al.  The phasor approach to fluorescence lifetime imaging analysis. , 2008, Biophysical journal.

[41]  M. Jäättelä,et al.  Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium , 2007, Cell Death and Differentiation.

[42]  Amy S. Lee.  GRP78 induction in cancer: therapeutic and prognostic implications. , 2007, Cancer research.

[43]  Afshin Samali,et al.  Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.

[44]  M. Demierre.  Epidemiology and prevention of cutaneous melanoma , 2006, Current treatment options in oncology.

[45]  F. Waharte,et al.  Setup and characterization of a multiphoton FLIM instrument for protein–protein interaction measurements in living cells , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[46]  P. Codogno,et al.  Regulation and role of autophagy in mammalian cells. , 2004, The international journal of biochemistry & cell biology.

[47]  I. Braakman,et al.  Quality control in the endoplasmic reticulum protein factory , 2003, Nature.

[48]  J Auwerx,et al.  PPARgamma, the ultimate thrifty gene. , 1999, Diabetologia.

[49]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[50]  B. Thiers.  Immunotherapy of malignant melanoma. , 1982, Journal of the American Academy of Dermatology.

[51]  A. Chadli.  THE CANCER CELL , 1924, La Presse medicale.